{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:39:59Z","timestamp":1753519199997},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11910-001-0057-z","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T13:38:07Z","timestamp":1180100287000},"page":"526-532","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Herpes zoster infection and postherpetic neuralgia"],"prefix":"10.1007","volume":"1","author":[{"given":"Richard B.","family":"Tenser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"57_CR1","first-page":"19","volume":"39","author":"DH Gilden","year":"1992","unstructured":"Gilden DH, Mahalingam R, Dueland A, Cohrs R: Herpes zoster: pathogenesis and latency. Prog Med Virol 1992, 39:19\u201375.","journal-title":"Prog Med Virol"},{"key":"57_CR2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0025-6196(11)63996-7","volume":"74","author":"T Liesegang","year":"1999","unstructured":"Liesegang T: Varicella zoster viral disease. Mayo Clin Proc 1999, 74:983\u2013998. A discussion of varicella-zoster viral (VZV) disease and biology. Acute VZV infection and recurrent zoster clinical presentation and treatment are discussed.","journal-title":"Mayo Clin Proc"},{"key":"57_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.1957.02980030041010","volume":"164","author":"CF Burgoon Jr","year":"1957","unstructured":"Burgoon CF Jr, Burgoon JS, Baldridge GD: The natural history of herpes zoster. JAMA 1957, 164:265\u2013269.","journal-title":"JAMA"},{"key":"57_CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1212\/WNL.22.5.459","volume":"22","author":"JE Thomas","year":"1972","unstructured":"Thomas JE, Howard FM Jr: Segmental zoster paresis\u2014a disease profile. Neurology 1972, 22:459\u2013466.","journal-title":"Neurology"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/brain\/115.2.383","volume":"115","author":"M Schmidbauer","year":"1992","unstructured":"Schmidbauer M, Budka H, Pilz P, et al.: Presence, disturbance and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992, 115:383\u2013398.","journal-title":"Brain"},{"key":"57_CR6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneur.1983.04050070075020","volume":"40","author":"R Muder","year":"1983","unstructured":"Muder R, Lumish R, Corsello G: Myelopathy after herpes zoster. Arch Neurol 1983, 40:445\u2013446.","journal-title":"Arch Neurol"},{"key":"57_CR7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.47.4.929","volume":"47","author":"SM De Silva","year":"1996","unstructured":"De Silva SM, Mark AS, Gilden DH, et al.: Zoster myelitis: improvement with antiviral therapy in two cases. Neurology 1996, 47:929\u2013931.","journal-title":"Neurology"},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ana.410140509","volume":"14","author":"DC Hilt","year":"1983","unstructured":"Hilt DC, Buchholz D, Krumholz A, et al.: Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angitis: diagnosis and management approaches. Ann Neurol 1983, 14:543\u2013553.","journal-title":"Ann Neurol"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/ana.410370612","volume":"37","author":"C Amlie-Lefond","year":"1995","unstructured":"Amlie-Lefond C, Kleinschmit-Demaster BK, Mahalingam R, et al.: The vasculopathy of varicella-zoster virus encephalopathy. Ann Neurol 1995, 37:784\u2013790.","journal-title":"Ann Neurol"},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.410350505","volume":"35","author":"DH Gilden","year":"1994","unstructured":"Gilden DH, Wright RR, Schneck SA, et al.: Zoster sine herpete, a clinical variant. Ann Neurol 1994, 35:530\u2013533.","journal-title":"Ann Neurol"},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1073\/pnas.93.5.2122","volume":"93","author":"R Mahalingam","year":"1996","unstructured":"Mahalingam R, Wellish M, Cohrs R, et al.: Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A 1996, 93:2122\u20132124.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1073\/pnas.95.12.7080","volume":"95","author":"O Lungu","year":"1998","unstructured":"Lungu O, Panagiotidis C, Annunziato P, et al.: Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc Natl Acad Sci U S A 1998, 95:7080\u20137085.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1073\/pnas.85.24.9773","volume":"85","author":"KD Croen","year":"1988","unstructured":"Croen KD, Ostrove JM, Dragovic LJ, Straus SE: Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster virus and herpes simplex viruses. Proc Natl Acad Sci U S A 1988, 85:9773\u20139777.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1073\/pnas.95.8.4658","volume":"95","author":"P Kennedy","year":"1998","unstructured":"Kennedy P, Grinfeld E, Gow J: Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 1998, 95:4658\u20134662.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/viro.1993.1115","volume":"193","author":"J Meier","year":"1993","unstructured":"Meier J, Holman R, Croen K, et al.: Varicella-zoster virus transcription in human trigeminal ganglia. Virology 1993, 193:193\u2013200.","journal-title":"Virology"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1128\/jvi.70.5.2789-2796.1996","volume":"70","author":"R Cohrs","year":"1996","unstructured":"Cohrs R, Barbour M, Gilden D: Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virology 1996, 70:2789\u20132796.","journal-title":"J Virology"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJM199607043350107","volume":"335","author":"RG Kost","year":"1996","unstructured":"Kost RG, Straus SE: Postherpetic neuralgia\u2014pathogenesis, treatment and prevention. N Engl J Med 1996, 335:32\u201342.","journal-title":"N Engl J Med"},{"key":"57_CR18","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/514271","volume":"178","author":"MJ Wood","year":"1998","unstructured":"Wood MJ, Shukla S, Fiddian AP, Crooks RJ: Treatment of acute herpes zoster: effect of early (<48h) versus late (48-72h) therapy with acyclovir and valacyclovir on prolonged pain. J Infect Dis 1998, 178:S81-S84.","journal-title":"J Infect Dis"},{"key":"57_CR19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","volume":"130","author":"J Cohen","year":"1999","unstructured":"Cohen J, Brunnell P, Straus S, Krause P: Recent advances in varicella-zoster virus infection. Ann Intern Med 1999, 130:922\u2013932. A discussion of multiple aspects of varicella-zoster virus (VZV) infection. Included is discussion of the VZV vaccine and the treatment of acute VZV infection and postherpetic neuralgia.","journal-title":"Ann Intern Med"},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJM198803033180904","volume":"318","author":"R Lawrence","year":"1988","unstructured":"Lawrence R, Gershon AA, Holtzman R, et al.: The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988, 318:543\u2013548.","journal-title":"N Engl J Med"},{"key":"57_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/WNL.51.1.17","volume":"51","author":"RB Tenser","year":"1998","unstructured":"Tenser RB: Trigeminal neuralgia. Neurology 1998, 51:17\u201319.","journal-title":"Neurology"},{"key":"57_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0733-8619(18)30811-9","volume":"7","author":"CP Watson","year":"1989","unstructured":"Watson CP: Postherpetic neuralgia. Neurol Clin 1989, 7:231\u2013248.","journal-title":"Neurol Clin"},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0304-3959(89)90001-8","volume":"39","author":"MC Rowbotham","year":"1989","unstructured":"Rowbotham MC, Fields HL: Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperatures. Pain 1989, 39:129\u2013144.","journal-title":"Pain"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jnnp.53.2.135","volume":"53","author":"T Nurmikko","year":"1990","unstructured":"Nurmikko T, Bowsher D: Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 1990, 53:135\u2013141.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"57_CR25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.148.7.1561","volume":"148","author":"JJ Rusthoven","year":"1988","unstructured":"Rusthoven JJ, Ahlgren P, Elhakim T, et al.: Varicella-zoster infection in adult cancer patients: a population study. Arch Intern Med 1988, 148:1561\u20131566.","journal-title":"Arch Intern Med"},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0002-9343(88)90366-X","volume":"85","author":"HH Balfour","year":"1988","unstructured":"Balfour HH: Varicella zoster virus infections in immunocompromised hosts: a review of the natural history and management. Am J Med 1988, 85:68\u201373.","journal-title":"Am J Med"},{"issue":"suppl 1","key":"57_CR27","first-page":"S41","volume":"178","author":"RJ Whitley","year":"1998","unstructured":"Whitley RJ, Shukla S, Crooks RJ: The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis 1998, 178 (suppl 1):S41-S42. Discussion of risk factors for the development of postherpetic neuralgia. Prodromal pain, severity of zoster pain, and age were the greatest risk factors.","journal-title":"J Infect Dis"},{"key":"57_CR28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13550289509111018","volume":"1","author":"R Mahalingham","year":"1995","unstructured":"Mahalingham R, Wellish M, Brucklie J, Gilden DH: Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1995, 1:130\u2013133.","journal-title":"J Neurovirol"},{"key":"57_CR29","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.51.5.1405","volume":"51","author":"M Haanp\u00e4\u00e4s","year":"1998","unstructured":"Haanp\u00e4\u00e4s M, Dastidar P, Weinberg A, et al.: CSF and MRI findings in patients with acute herpes zoster. Neurology 1998, 51:1405\u20131411.","journal-title":"Neurology"},{"key":"57_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3959(91)90124-G","volume":"44","author":"CP Watson","year":"1991","unstructured":"Watson CP, Deck JH, Morshead C, et al.: Postherpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991, 44:105\u2013117.","journal-title":"Pain"},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ana.410200602","volume":"20","author":"RK Portenoy","year":"1986","unstructured":"Portenoy RK, Duma C, Foley KM: Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986, 20:651\u2013664.","journal-title":"Ann Neurol"},{"key":"57_CR32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1302\/0301-620X.51B4.593","volume":"51B","author":"SK Gupta","year":"1969","unstructured":"Gupta SK, Helal BH, Kiely P: The prognosis in zoster paralysis. J Bone Joint Surg 1969, 51B:593\u2013603.","journal-title":"J Bone Joint Surg"},{"key":"57_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0022-510X(76)90115-5","volume":"28","author":"C Gardner-Thorpe","year":"1976","unstructured":"Gardner-Thorpe C, Foster JB, Barwick DD: Unusual manifestations of herpes zoster. J Neurol Sci 1976, 28:427\u2013447.","journal-title":"J Neurol Sci"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00687229","volume":"52","author":"M Ruppenthal","year":"1980","unstructured":"Ruppenthal M: Changes of the central nervous system in herpes zoster. Acta Neuropathol 1980, 52:59\u201368.","journal-title":"Acta Neuropathol"},{"key":"57_CR35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.1981.00510100096020","volume":"38","author":"LG Reimer","year":"1981","unstructured":"Reimer LG, Reller LB: CSF in herpes zoster meningoencephalitis. Arch Neurol 1981, 38:668.","journal-title":"Arch Neurol"},{"key":"57_CR36","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/514271","volume":"178","author":"MJ Wood","year":"1998","unstructured":"Wood MJ, Shukla S, Fiddian AP, Crooks RJ: Treatment of acute herpes zoster: effect of early (<48h) versus late (8-72 h) therapy with acyclovir and valacyclovir on prolonged pain. J Infect Dis 1998, 178:S81-S84. Early antiviral treatment is important in decreasing varicella-zoster virus-associated pain.","journal-title":"J Infect Dis"},{"key":"57_CR37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","volume":"125","author":"RJ Whitley","year":"1996","unstructured":"Whitley RJ, Weiss H, Gnann JW Jr, et al.: Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med 1996, 125:376\u2013383.","journal-title":"Ann Intern Med"},{"key":"57_CR38","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","volume":"39","author":"KR Beutner","year":"1995","unstructured":"Beutner KR, Friedman DJ, Forszpaniak C, et al.: Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995, 39:1546\u20131553.","journal-title":"Antimicrob Agents Chemother"},{"key":"57_CR39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","volume":"123","author":"S Tyring","year":"1995","unstructured":"Tyring S, Barbarash RA, Nahlik JE, et al.: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann Intern Med 1995, 123:89\u201396.","journal-title":"Ann Intern Med"},{"key":"57_CR40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199403313301304","volume":"330","author":"MJ Wood","year":"1994","unstructured":"Wood MJ, Johnson RW, Mckenchick MW, et al.: A randomized trial of acyclovir for 7 or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994, 330:896\u2013900.","journal-title":"N Engl J Med"},{"key":"57_CR41","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","volume":"325","author":"I Hardy","year":"1991","unstructured":"Hardy I, Gershon AA, Steinberg SP, LaRussa P: The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 1991, 325:1545\u20131550.","journal-title":"N Engl J Med"},{"key":"57_CR42","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1056\/NEJM200011233432110","volume":"343","author":"CP Watson","year":"2000","unstructured":"Watson CP: A new treatment for postherpetic neuralgia. N Engl J Med 2000, 343:1563\u20131565. An editorial in response to Kotani et al. [47]. This is an authoritative discussion of postherpetic neuralgia.","journal-title":"N Engl J Med"},{"key":"57_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0885-3924(97)00077-8","volume":"13","author":"D Bowsher","year":"1997","unstructured":"Bowsher D: The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline. J Pain Symptom Management 1997, 13:327\u2013331.","journal-title":"J Pain Symptom Management"},{"key":"57_CR44","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","volume":"280","author":"MC Rowbotham","year":"1998","unstructured":"Rowbotham MC, Harden N, Stacey B, et al.: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998, 280:1837\u20131842.","journal-title":"JAMA"},{"key":"57_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","volume":"65","author":"MC Rowbotham","year":"1996","unstructured":"Rowbotham MC, Davies PS, Verkempinck C, et al.: Lidocaine patch: double blind controlled study of a new treatment method for postherpetic neuralgia. Pain 1996, 65:39\u201344.","journal-title":"Pain"},{"key":"57_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0006-8993(78)90146-4","volume":"152","author":"TM Jessell","year":"1978","unstructured":"Jessell TM, Iversen LL, Cuello AC: Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res 1978, 152:183\u2013188.","journal-title":"Brain Res"},{"key":"57_CR47","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJM200011233432102","volume":"343","author":"N Kotani","year":"2000","unstructured":"Kotani N, Kushikata T, Hashimoto H, et al.: Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000, 343:1514\u20131519. A report of effective treatment of postherpetic neuralgia. Efficacy of treatment also suggests possible mechanisms of postherpetic neuralgia.","journal-title":"N Engl J Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0057-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-001-0057-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0057-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0057-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:45:39Z","timestamp":1659095139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-001-0057-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s11910-001-0057-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}